This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7http://dx.doi.org/10.1046/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73701966
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в серпні 2003 artículu científicu espublizáu n'agostu de 2003 im August 2003 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2003 wetenschappelijk artikel scientific article published on 01 August 2003
p:P577
wds:Q73701966-55AC32B1-17C7-4697-BD9C-B3F9D562D4CF
wdt:P577
2003-08-01T00:00:00Z
p:P407
wds:Q73701966-C6D341A2-95AC-480E-93BF-D404B68216AA
wdt:P407
wd:Q1860
p:P2093
wds:Q73701966-EFB2EC55-70CA-41DF-960C-1EDDA329AAC4 wds:Q73701966-A07AA291-1E9D-4D1D-9C68-73A9905BB212 wds:Q73701966-5AFE9F37-3460-4BDE-B9F1-022A9E7E5D05
wdt:P2093
Moshe Yeshurun Abraham Avigdor Pia Raanani
rdfs:label
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
skos:prefLabel
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
schema:name
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
p:P50
wds:Q73701966-A7E7108C-F8C0-4630-BF01-9157C5B56E53 wds:Q73701966-ED6F3567-6240-4358-88AA-B873BF831F10 wds:Q73701966-F2D3BD59-9348-45D0-914E-8456B8A776B8 wds:Q73701966-6518B524-C635-45D2-87B2-4F3974707CF2
wdt:P50
wd:Q123134938 wd:Q106212163 wd:Q88346482 wd:Q115760917
p:P1476
wds:Q73701966-4689BC95-94EE-4449-AEF5-971B910C635B
wdt:P1476
Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
p:P304
wds:Q73701966-7F9AA781-0648-468F-87AC-E0C1220570DF
wdt:P304
457-464
p:P31
wds:Q73701966-7ABC8B53-D81F-4398-A0B4-C70324503881
wdt:P31
wd:Q13442814
p:P921
wds:Q73701966-2E69630D-7D6D-4927-A0E6-5D3BFDA240BB wds:Q73701966-AC945052-5EEC-41E3-8E6D-D9FECE653A0C
wdt:P921
wd:Q412323 wd:Q65592366
p:P698
wds:Q73701966-81ED76EB-D43B-4567-8929-1BD8009C3549
wdtn:P698
n12:12877674
wdt:P698
12877674
p:P1433
wds:Q73701966-8ADE1EE8-8947-4C4C-9257-03DB85885D06
wdt:P1433
wd:Q4970200
p:P433
wds:Q73701966-F74C9AF0-4F4C-4BF4-958D-B47DDDCA01E3
p:P478
wds:Q73701966-B55812BC-F105-4A72-A324-09ACF2066145
wdt:P433
3
wdt:P478
122
p:P356
wds:Q73701966-F8AAD6E4-8B95-45F5-B854-55B5CCCAAA23
wdtn:P356
n7:J.1365-2141.2003.04446.X
wdt:P356
10.1046/J.1365-2141.2003.04446.X